Stryker

Stryker Liabilities

The The Liabilities of Stryker (SYK) as of Oct 18, 2026 is 25.42 B USD. In the previous year, The Liabilities was 22.34 B USD — a change of 13.82% (higher).

Liabilities

25.42 BUSD

YoY

13.82%

Last updated:

In 2025, Stryker's total liabilities amounted to 25.42 B USD, a 13.82% difference from the 22.34 B USD total liabilities in the previous year.

The Stryker Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Liabilities
Date
Liabilities
Jan 1, 2018
15.50 B USD
Jan 1, 2019
17.36 B USD
Jan 1, 2020
21.25 B USD
Jan 1, 2021
19.75 B USD
Jan 1, 2022
20.27 B USD
Jan 1, 2023
21.32 B USD
Jan 1, 2024
22.34 B USD
Jan 1, 2025
25.42 B USD
The Stryker Liabilities history
YEARLiabilitiesYoY
25.42 BUSD+13.82%
22.34 BUSD+4.78%
21.32 BUSD+5.19%
20.27 BUSD+2.60%
19.75 BUSD-7.02%
21.25 BUSD+22.38%
17.36 BUSD+12.01%
15.50 BUSD+27.16%
12.19 BUSD+11.98%
10.89 BUSD+40.71%
7.74 BUSD-15.15%
9.12 BUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Stryker Stock analysis

What does Stryker do? Stryker Corp is a global medical technology company based in Kalamazoo, Michigan, USA. It was founded by Dr. Homer Stryker in 1941 and has since become one of the world's leading providers of medical devices, implants, and medical instruments and accessories. The history of Stryker Corp began over 80 years ago with the invention of the "Gipsbruch", a device developed by Dr. Homer Stryker to better treat broken bones. The Gipsbruch marked the beginning of a new era in orthopedics and led to a comprehensive redefinition of patient care. Over the following decades, Stryker Corp developed further life-saving products and solutions that are used worldwide. Stryker Corp offers a wide range of medical devices, implants, instruments, and accessories to support patient care. The company pursues a strategic growth strategy focused on innovation and acquisitions. This includes the development and marketing of new technologies to enhance patients' quality of life. Stryker Corp is divided into three main divisions: Orthopedics, Medical Technology, and Neurotechnology. The Orthopedics division specializes in the development and manufacturing of implants, instruments, and devices for the treatment of musculoskeletal disorders. The Medical Technology division focuses on the development and manufacturing of devices to support surgical procedures and diagnostics in areas such as endoscopy and emergency medicine. The Neurotechnology division specializes in the development and manufacturing of products for the treatment of neurological disorders such as epilepsy, Parkinson's disease, and hydrocephalus. Some of Stryker Corp's well-known products include the Gipsbruch, which has become a standard device in orthopedics. Other significant products include the hip implant system and the knee implant system, which are widely used and successful in many countries worldwide. Another product of Stryker Corp is the Neptune System, a surgical system that enables the safe and effective use of fluids and gases during surgical procedures. Overall, Stryker Corp is a global medical technology company that originated from the invention of the Gipsbruch and is now one of the leading companies in the manufacturing and development of medical devices and instruments. The company pursues a growth strategy based on innovation and acquisitions and has already produced many successful products. The different divisions, Orthopedics, Medical Technology, and Neurotechnology, each focus on different medical disciplines and offer a wide range of products and solutions to support patient care. Stryker is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing Stryker's Liabilities

Stryker's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Stryker's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Stryker's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Stryker's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Stryker’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Stryker stock

The Liabilities of Stryker is 25.42 B USD in 2025.

The Liabilities of Stryker changed from 22.34 B USD to 25.42 B USD, representing a 13.82% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities Stryker since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's Stryker historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Stryker

All Key Metrics — Stryker